Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
IGM Biosciences, Inc. | PRINCIPAL ACCOUNTING OFFICER | Common Stock | 32.2K | $372K | $11.54 | Nov 7, 2024 | Direct |
IGM Biosciences, Inc. | PRINCIPAL ACCOUNTING OFFICER | Stock Option (right to buy) | 37.5K | Mar 12, 2024 | Direct | ||
Aeglea BioTherapeutics, Inc. | VP, Controller&Princ Acctg Off | Employee Stock Option (right to buy) | 30K | Feb 17, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IGMS | IGM Biosciences, Inc. | Nov 7, 2024 | 1 | $0 | 4 | Nov 12, 2024 | PRINCIPAL ACCOUNTING OFFICER |
IGMS | IGM Biosciences, Inc. | Sep 13, 2024 | 1 | -$5.41K | 4 | Sep 17, 2024 | PRINCIPAL ACCOUNTING OFFICER |
IGMS | IGM Biosciences, Inc. | Jun 14, 2024 | 1 | -$3.75K | 4 | Jun 18, 2024 | PRINCIPAL ACCOUNTING OFFICER |
IGMS | IGM Biosciences, Inc. | Mar 13, 2024 | 2 | -$9.94K | 4 | Mar 15, 2024 | PRINCIPAL ACCOUNTING OFFICER |
IGMS | IGM Biosciences, Inc. | Mar 12, 2024 | 2 | $0 | 4 | Mar 14, 2024 | PRINCIPAL ACCOUNTING OFFICER |
IGMS | IGM Biosciences, Inc. | Apr 4, 2023 | 2 | $0 | 4 | Apr 6, 2023 | Principal Accounting Officer |
IGMS | IGM Biosciences, Inc. | May 25, 2022 | 0 | $0 | 3 | Jun 3, 2022 | Principal Accounting Officer |
AGLE | Aeglea BioTherapeutics, Inc. | Feb 17, 2022 | 1 | $0 | 4 | Feb 22, 2022 | VP, Controller&Princ Acctg Off |